Astragalus polysaccharides: An effective treatment for diabetes prevention in NOD mice

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue 8, 2008, Pages 468-474

  Chen, W ^a   Li, Y M ^a,b   Yu, M H ^a  

^a FUDAN UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Astralagus polysaccharides; Diabetes; Gene expression; Immunology

Indexed keywords

ASTRAGALUS EXTRACT; C PEPTIDE; FAS LIGAND; GAMMA INTERFERON; GLUCOSE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; POLYSACCHARIDE; PROTEIN BCL 2; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4 CD8 RATIO; CHINESE HERB; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; ASTRAGALUS PLANT; BODY WEIGHT; DIABETES MELLITUS, TYPE 1; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; PLANT EXTRACTS; POLYSACCHARIDES;

EID: 54549118063     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1058081     Document Type: Article

References (21)

1. Ahraham RS, Wen L, Marientta EV. Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase 65-specific T cells in a transgenic model. J Immunol 2001; 166: 1370-1389
2. Chen W, Li YM, Yu MH. Immunoloregulation effects of astragalus polysaccharides on T Helper lymphocyte subgroups in nonobese diabetic mice. Chinese J Modern Medicine 2007; 17 (1): 28-31
3. I Chen W, Li YM, Yu MH. Effects of Astragalus polysaccharides on chymase, angiotensin- converting enzyme and angiotensin II in diabetic cardiomyopathy in hamsters. J Int Med Res 2007; 35 (6): 873-877
4. Choquet KG, Ducluzeau M, Nicolas TR. Increased production of interferon-gamma, but not IL-4 mRNA, by streptozotocin in the popliteal lymph node assay. J Appl Toxicol 2000; 20: 175-187
5. Christen U, Wolfe T, Mohrle U. A dual role for TNF-α in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 2001; 166 (2): 7023-7032
6. Cong L, Li YM, Yu MH. Effect of Astragalus polysaccharides on the expression of myocardial collagen in hamsters with diabetic cardiomyopathy. Chinese J Clinical rehabilitation 2006; 10 (7): 64-66
7. Farilla L, Dotta F, Mario U Di. Presence of interleukin 4 or interleukin 10, but not both cytokines, in pancreatic tissue of two patients with recently diagnosed diabetes mellitus typeI. Autoimmunity 2000; 32: 1161-1186
8. Glowacka E, Banasik M, Lewkowicz P. The effect of LPS on neutrophils from patients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro. Scand J Immunol 2002; 55 (2): 210-217
9. Grewal IS, Grewal KD, Wong FS. Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism. J Autoimmun 2002; 19 (1-2): 9-22
10. Heitmeirer MR, Arnush M, Scarim AL. Pancreatic beta cell damage mediated by beta-cell production of interleukin-1: A novel mechanism for virus-induced diabetes. J Biol Chem 2001; 276 (14): 1151-1158
11. Hill NJ, Gunst K Van, Sarvetnick N. Th1 and Th2 pancreatic inflammation differentially affects homing of islet- reactive CD4 cells in non-obese diabetic mice. J Immunol 2003; 170 (4): 1649-1658
12. Hirai H, Kaino Y. Analysis of cytokine mRNA expression in pancreatic islets if nonobese diabetic mice. J Pediatr Endocrinol Metab 2000; 13: 91-114
13. Karlsson MG, Lawesson SS, Ludvigsson J. Th1-like dominance in high-risk first-degree relatives f type 1 diabetic patients. Diabetologia 2000; 43: 742-766
14. Liu J, Beller DI. Distinct pathways for NF-kappa B regulation are associated with aberrant macrophage IL-12 production in lupus- and diabetes-prone mouse strains. J Immunol 2003: 170 (9): 4489-4496
15. Ni Y, Su Q, Liu X. Experimental study of potimized techniques of water decoction extraction of Astragalus polysaccharide. China J Chin Medicine 1998; 23 (6): 284-286
16. Phillips JM, Browe GL, Chancey AL, Thanigaraj S. Nondepleting Anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic β cells. J Immunol 2000; 165 (4): 1949-1958
17. Rajagopalan G, Kudva YC, Flavell RA. Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules. Diabetes 2003; 52 (2): 342-327
18. Sparre T, Christensen UB, Mose Larsen P. IL-1beta induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysis. Diabetologia 2002; 45 (11): 1550-1561
19. Ventura OD, Vilella CA, Zanin ME. Kinetics of TNF-alpha and IFN-gamma mRNA expression in islets and spleen of NOD mice. Braz J Med Biol Res 2002; 35 (11): 1347-1355
20. Wu Y, Ou-Yang JP, Wu K, Wang Y, Zhou YF, Wen CY. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B. Acta Pharmacol Sin 2005; 26 (3): 345-352
21. Zhang YC, Pileggi A, Agarwal A. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes 2003; 52 (3): 708-716